Press release
Intermediate Age-Related Macular Degeneration (AMD) Market to Reach USD 6.17 Billion by 2034
Intermediate Age-Related Macular Degeneration
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72231
Market Summary
The Intermediate AMD Market is expanding as early detection and monitoring of AMD become central to preventing progression to advanced disease stages such as geographic atrophy (GA) or neovascular (wet) AMD. Intermediate AMD is characterized by medium-to-large drusen deposits and pigmentary abnormalities in the macula, placing patients at high risk of significant vision loss.
Diagnostic advances-including optical coherence tomography (OCT), fundus autofluorescence (FAF), OCT angiography (OCTA), fundus photography, and AI-powered retinal analytics-are enabling earlier identification and predictive risk modeling. Nutritional management via AREDS2 supplements, lifestyle counseling, and emerging pharmacologic interventions targeting complement pathways, inflammation, and mitochondrial dysfunction are shaping clinical care strategies. North America and Europe dominate the diagnosed patient pool due to high retinal screening rates, while Asia-Pacific is the fastest-growing region, driven by rapid population aging and improved ophthalmic care access.
Key Takeaways
• 2024 Market Size: USD 3.42 Billion
• 2034 Forecast: USD 6.17 Billion
• CAGR: 6.0% (2025-2034)
• Growth driven by retinal imaging expansion & rising AMD screening rates
• Increasing focus on preventing progression to GA & wet AMD
• Asia-Pacific witnessing fastest patient pool expansion
Market Drivers
• Rapid global increase in the population aged 55+
• Advancements in retinal imaging enabling earlier diagnosis
• Growing adoption of AREDS2 supplementation and evidence-based care
• Rising investment in complement inhibitors & early AMD drug development
• Increased public awareness of age-related retinal diseases
Segmentation Snapshot
By Disease Stage
• Early AMD
• Intermediate AMD (Focus Segment)
• Progression Risk Categories
By Treatment Approach
• AREDS2 Supplements
• Lifestyle & Nutritional Management
• Emerging Early-Stage Therapeutics
• Risk-Based Monitoring Protocols
• Vision Support & Counseling
By Diagnosis Method
• Optical Coherence Tomography (OCT)
• Fundus Autofluorescence (FAF)
• OCT Angiography (OCTA)
• Fundus Photography
• AI-Assisted Retinal Image Analysis
By End User
• Hospitals
• Ophthalmic Centers
• Retina Specialty Clinics
• Research Institutes
• Senior Eye Care Programs
By Region
• North America (Largest Share)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/72231/intermediate-amd-market
Recent Developments
• AI-driven early AMD detection tools gaining regulatory approvals.
• Development of early-stage complement pathway inhibitors entering clinical trials.
• Expansion of community-based retinal screening programs for aging populations.
• Improved OCT biomarkers enabling better prediction of AMD progression.
Expert Quote - Irfan Tamboli, Business Development Executive
"Intermediate AMD represents a critical window for intervention. With advanced diagnostics and emerging therapeutics, healthcare systems are now better positioned to slow or prevent progression to irreversible vision loss."
Conclusion
The Intermediate AMD Market will continue to grow through 2034 as early diagnosis improves, retinal imaging adoption increases, and new therapeutic candidates targeting early disease pathways advance through clinical development. Organizations investing in predictive ophthalmic AI, complement inhibition research, and senior retinal care programs will shape the future of AMD management.
This report is also available in the following languages : Japanese (中級AMD市場), Korean (중급 AMD 시장), Chinese (中端 AMD 市场), French (Marché intermédiaire AMD), German (Markt für AMD-Systeme für mittlere Anwender), and Italian (Mercato AMD intermedio), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72231
Related Reports
Age-related Macular Degeneration Market
https://exactitudeconsultancy.com/reports/72217/age-related-macular-degeneration-market
Dry Age-related Macular Degeneration Market
https://exactitudeconsultancy.com/reports/72227/dry-age-related-macular-degeneration-market
Wet Age-Related Macular Degeneration (Wet AMD) Market
https://exactitudeconsultancy.com/reports/72241/wet-age-related-macular-degeneration-wet-amd-market
Neovascular Age-related Macular Degeneration Market
https://exactitudeconsultancy.com/reports/72264/neovascular-age-related-macular-degeneration-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intermediate Age-Related Macular Degeneration (AMD) Market to Reach USD 6.17 Billion by 2034 here
News-ID: 4304160 • Views: …
More Releases from Exactitude Consultancy
Hyperkalemia Market in Japan to Reach USD 412.7 Million by 2034
Tokyo, Japan - December 2025 - The Japan Hyperkalemia Market, valued at USD 233.5 million in 2024, is projected to reach USD 412.7 million by 2034, growing at a 5.9% CAGR (2025-2034), according to Exactitude Consultancy. The rising prevalence of chronic kidney disease (CKD), heart failure, diabetes, and patients on renin-angiotensin-aldosterone system (RAAS) inhibitors is significantly increasing hyperkalemia burden across Japan.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71975
Market…
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Nearly USD 3.2 b …
Generalized Myasthenia Gravis (gMG) Market Enters Strong Growth Phase with Breakthrough Biologic Therapies
Snippet / Teaser:
The global Generalized Myasthenia Gravis (gMG) market is witnessing accelerated growth as awareness improves, advanced biologic therapies gain adoption, and rare-disease healthcare infrastructure expands worldwide. With rising diagnosis rates and strong therapy pipelines, gMG is emerging as a high-value segment in autoimmune and neuromuscular disorder treatment.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72089
1. Keyword Definition…
Granulomatosis with Polyangiitis (GPA) Market to Reach USD 595.2 Million by 2034
Pune, India - December 2025 - The global Granulomatosis with Polyangiitis (GPA) Market, valued at USD 344.7 million in 2024, is projected to reach USD 595.2 million by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising autoimmune disease detection, greater utilization of ANCA testing, and advancements in biologic therapies are contributing to market expansion.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72286
Market Summary
The Granulomatosis with…
Dravet Syndrome (DS) Market Poised for Growth as Awareness and Therapeutic Advan …
With increasing diagnosis rates, rising awareness of rare childhood epilepsies, and growing innovations in therapy, the global Dravet Syndrome (DS) market is expected to expand significantly - offering new hope to patients and growth opportunities for healthcare stakeholders worldwide.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72087
1. Keyword Definition - Dravet Syndrome (DS)
Dravet Syndrome (DS) is a rare, severe, treatment-resistant epilepsy syndrome that typically begins in infancy or early childhood.…
More Releases for AMD
Onlive Server Brings AI-Powered AMD Dedicated Servers
We are all aware of how useful, and sometimes even crucial, proper hosting services can be for a business. That is why Onlive Server is providing this new option with the newly recommended AI-powered AMD Dedicated Server Hosting[https://onliveserver.com/amd-dedicated-server-hosting/]. Furthermore, these servers are powered by AMD technology and do superbly in servicing the tremendous demand of agile business workloads with modern AI computations, big data, and other emerging technologies.
AI-powered solutions are…
Age-Related Macular Degeneration Market To Expand, Fuelled By Innovations In Dry …
The Age-related Macular Degeneration Market (AMD) is poised for significant growth over the coming years, with projections indicating a compound annual growth rate (CAGR) of 6.2%, leading to an estimated market value of $20 billion by the end of the forecast period. This robust expansion is driven by several critical factors, including the rising prevalence of eye diseases, advancements in medical technology, and an aging population that is increasingly susceptible…
AMD Workstations Market | BIZON, BOXX Technologies, Broadberry, Dell
The global amd workstations market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the amd workstations market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth of the…
Airway Management Products (AMD) Market 2021 | Detailed Report
Airway Management Products (AMD) Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5262437
The report provides a comprehensive analysis of company profiles listed below:
- Medtronic
- Teleflex
- Ambu
- Smiths Medical
- Intersurgical
- Becton Dickinson
- Armstrong Medical
- Medline Industries
Airway Management Products…
Age-Related Macular Degeneration (AMD) Market Report 2018: Segmentation by Type …
Global Age-Related Macular Degeneration (AMD) market research report provides company profile for F. Hoffmann-La Roche AG, Regeneron Pharmaceutical Inc., Novartis AG, Bayer AG, Santen Pharmaceuticals and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc.…
Global Microprocessor Market 2018 - Intel, Qualcomm, Apple, AMD
Apex Market Reports, recently published a detailed market research study focused on the “Microprocessor Market” across the global, regional and country level. The report provides 360° analysis of “Microprocessor Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Microprocessor on the basis of…
